Truist Securities Maintains Hold on Aveanna Healthcare Hldgs, Raises Price Target to $9

Benzinga Newsdesk www.benzinga.com Positive 77.2%

Neg 0% Neu 0% Pos 77.2%

Truist Securities analyst David Macdonald maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Hold and raises the price target from $8 to $9.